Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetaminophen versus ibuprofen for closure of patent ductus arteriosus in hospitalized neonates
IRCT20230917059446N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of acetaminophen and ibuprofen in patent ductus arteriosus (PDA) (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoint: Closed ductus arteriosus in echocardiography. Started Oct 2025; status: completed.
02
Drugs
acetaminophenibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20230917059446N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230917059446N1.